AstraZeneca Biobank Renewal 2022

• Research type

  Research Tissue Bank

• IRAS ID

  313152

• Research summary

  AstraZeneca UK Biobank

• REC name

  North West - Haydock Research Ethics Committee

• REC reference

  22/NW/0102

• Date of REC Opinion

  28 Apr 2022

• REC opinion

  Favourable Opinion

• Data collection arrangements

  The Biobank receives surgical tissues, blood, plasma, serum, urine, other body fluids and cells; all surplus to diagnostic and therapeutic requirements or samples taken as part of an approved study/research protocol. Samples are from individuals with various disease types and normal biological samples may also be stored. A minimal
  proportion of material is sourced from the deceased.
  Samples and data are sourced from a variety of suppliers and collaborators according to researcher requirements. Suppliers must comply with AstraZeneca's policies and procedures, particularly with regards to the informed consent process.
  All samples are stored at the main biobank hub or satellite sites.

• Research programme

  Human biological samples play a vital role in AstraZeneca Research and Development, helping to build a deeper understanding of human disease processes and their underlying mechanisms, and in developing new medicines by enabling earlier and better predictions about their effectiveness and safety.

• Storage license

  12109

• RTBTitle

  AstraZeneca UK Biobank

• Establishment organisation

  AstraZeneca

• Establishment organisation address

  Babraham Building BSU 650

  Babraham Research Campus

  Babraham, Cambridge

  CB21 4AT